Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iTeos Therapeutics, Inc. - Common Stock (NQ: ITOS )

7.320 -0.140 (-1.88%)
Streaming Delayed Price Updated: 2:06 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iTeos Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The One-Minute Market Report - Sunday, Sept. 22
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, exchange-traded funds, and stocks that moved the market higher, as well as the market segments... 
Via Talk Markets
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
Nuvalent and Iteos delivered promising updates in their lung cancer studies. But three patients died in one test. 
Via Investor's Business Daily
Topics Death
Exposures Death
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Recap: ITeos Therapeutics Q4 Earnings
Via Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
Via Benzinga
Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. 
Via Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Thursday following the CPI data, there were a few notable insider trades. 
Via Benzinga
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
Earlier today, Roche Holdings AG (OTC: RHHBY) announced that it had been made aware of inadvertent disclosure of the second interim analysis of Phase 3 SKYSCRAPER-01 study, evaluating tiragolumab plus... 
Via Benzinga
S&P 500 Gains 1%; Analog Devices Posts Downbeat Results
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Wednesday. The Dow traded up 0.51% to 34,462.61 while the NASDAQ rose 1.60% to 13,722.24.... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Up Triple Digits, Headed for Much-Needed Win
Stocks are firmly higher this afternoon, despite Foot Locker dragging the athletic segment of the retail sector with its dismal forecast. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers AgileThought, Inc. (NASDAQ: AGIL) jumped 85.5% to $0.3941. AgileThought recently posted a loss for the second quarter. 
Via Benzinga
Why ITeos Therapeutics (ITOS) Stock Is Moving Higher
ITeos Therapeutics, Inc. (NASDAQ: ITOS) shares are trading higher Wednesday after the release of Roche's non-small cell lung cancer (NSCLC 
Via Benzinga
Crude Oil Edges Lower; VCI Global Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. The Dow traded up 0.40% to 34,425.29 while the NASDAQ rose 1.40% to 13,694.79. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Rises 1%; US Manufacturing PMI Falls In August
U.S. stocks traded higher this morning, with the Dow Jones gaining 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.32% to 34,397.25 while the NASDAQ rose 1.07% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
How Roche's Accidental Cancer Update Lifted Iteos And Arcus More Than 30%
Roche provided an update from its study in lung cancer using an anti-TIGIT drug. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.